New research may allow more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists (ASA), using functional magnetic resonance imaging (FMRI) to measure the brain’s neural response to pain may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development. This could provide the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.

The American College of Radiology’s ACR 2016 annual meeting offers sessions on advanced data science tools, clinical decision support and electronic medical records (EMRs) optimization to help radiology professionals support enterprise imaging initiatives and adapt to new alternative payment models.

The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.

Predictive analytics platform Spreemo has entered into a strategic research partnership with the University Radiology Group (URG), one of the nation’s pre-eminent radiology practices performing approximately 1.8 million patient imaging exams annually. Spreemo, through its Quality Research Institute, and URG will jointly investigate the effect of various factors in the delivery of care, including patient diagnoses and how these impact the ensuing outcomes and overall cost.

February 3, 2016 — A new way of using magnetic resonance imaging (MRI) scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust.